GREGORY T SCHIFFMAN
CIK 1239011 · Chief Financial Officer · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.36M
Companies
8
Total Filings
92
Lifetime Open-Market Net
-$562.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FABC | Director | — | $2.48 | — | $0 | 1 | 2026-06-18 |
| StableX Technologies, Inc. (SBLX) Delisted | Director | — | $3.10 | — | $0 | 1 | 2025-10-31 |
| StableX Technologies, Inc. (AYRO) Delisted | Director | 107,400 | $7.08 | $760.4K | -$177.2K | 14 | 2024-12-02 |
| ABSI | Chief Financial Officer | 605,165 | $7.13 | $4.31M | $0 | 3 | 2023-03-03 |
| StableX Technologies, Inc. (DCAR) Delisted | Director | 6,329 | — | — | $0 | 2 | 2019-08-29 |
| IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2016-11-15 |
| STEM | Chief Financial Officer | 9,007 | $5.33 | $48.0K | $49.8K | 7 | 2016-04-18 |
| VNUS MEDICAL TECHNOLOGIES INC (VNUS) Delisted | Director | 5,000 | — | — | -$435.6K | 12 | 2009-06-17 |
Recent Filings · Page 3 of 10
92 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-10-01 | StableX Technologies, Inc. (AYRO) Delisted | Grant (A) | +75,412 | $0 | EDGAR |
| 2020-06-01 | StableX Technologies, Inc. (AYRO) Delisted | Grant (A) | +4,066 | $0 | EDGAR |
| 2019-08-29 | StableX Technologies, Inc. (DCAR) Delisted | Mixed | +50,815 | -$9.7K | EDGAR |
| 2018-12-03 | StableX Technologies, Inc. (DCAR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-15 | IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-04-18 | STEM | Buy (P) | +166,000 | $49.8K | EDGAR |
| 2016-04-18 | STEM | Grant (A) | +720,000 | $0 | EDGAR |
| 2016-03-21 | STEM | Grant (A) | +166,000 | $49.8K | EDGAR |
| 2016-01-12 | STEM | Tax (F) | −25,976 | -$9.9K | EDGAR |
| 2016-01-05 | STEM | Tax (F) | −38,307 | -$16.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.